BioLine RX Ltd ADR buy BiotechBee
Start price
03.09.23
/
50%
€1.97
Target price
31.07.25
€2.50
Performance (%)
18.78%
End price
06.09.23
€2.34
Summary
This prediction ended on 06.09.23 with a price of €2.34. The BUY prediction by BiotechBee finished with a performance of 18.78%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioLine RX Ltd ADR | - | - | - |
| iShares Core DAX® | 0.721% | 4.566% | 24.333% |
| iShares Nasdaq 100 | -0.413% | 1.884% | 8.848% |
| iShares Nikkei 225® | 3.500% | 7.196% | 24.030% |
| iShares S&P 500 | 0.489% | 2.436% | 6.048% |
According to BiotechBee what are the pros and cons of BioLine RX Ltd ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year